Meet Mitch: The CEO leading Canada’s largest CDMO dedicated to manufacturing for CGTs

Mitchel Sivilotti, CEO, OmniaBio Inc. OmniaBio Inc., a subsidiary of CCRM, is building the largest facility of its kind in Canada, providing specialized manufacturing to the flourishing cell and gene therapy (CGT) industry. The new contract development and manufacturing organization (CDMO) will focus on producing gene-modified cell therapies and viral vectors compliant with Good Manufacturing...

Continue reading


Right Turn: Regenerative medicine outside the university classroom

Now is a fantastic time to be an undergraduate student, graduate student or postdoc (sometimes referred to as trainees or highly qualified personnel) interested in regenerative medicine. In addition to the education you receive in the classroom or lab, your university will have department or student-run activities for networking or to help you enhance your...

Continue reading


Reflecting on and recapping ComSciConCAN 2022

This post is a collaborative effort, written by the ComSciConCAN2022 organizing committee: Katie Pullella, Ben Davis-Purcell, Shealin Murray, Shanzeh Mumtaz Ahmed and Francesco Zangari. ComSciConCAN 2022 group photo When the inaugural ComSciConCAN took place in 2019 at McMaster University, it emboldened Canadian graduate students to share their science beyond a traditional scientific conference. The results...

Continue reading


Right Turn: Seeking science distractions while on vacation

Hello from Alaska! I’m on vacation this week – hopefully you are as well. After many days at sea and lots of napping, reading, walking, spotting local wildlife, eating, Netflix and Wordle, it’s time for something that feels like work without being work. Since I haven’t shared a good science parody video in a looong...

Continue reading


Catching up with ExCellThera and co-founder Guy Sauvageau

Dr. Guy Sauvageau. Photo credit: IRIC Launched in June of 2015, ExCellThera is a clinical-stage biotechnology company making strides in developing robust and cost-effective processes for growing blood stem cells for therapeutic use, backed by award-winning proprietary technology. The company was founded based on a key molecule discovered by Drs. Guy Sauvageau and Anne Marinier...

Continue reading


Right Turn: Dance, draw, sing and joke your way through science communications!

Scientists are clever people so I guess we shouldn’t be surprised at all the different art forms they have mastered to do science communications. I have compiled some great examples below, but welcome others. Feel free to share some of your favourites in the comment section. Using dance to explain science is not new; nevertheless,...

Continue reading


Target product profile: Starting that journey of a thousand miles with the right first step

This post is by Harmanpreet Harmanpreet, who interned with CCRM Australia. The CCRM Australia Training Program seeks to facilitate training for the future workforce of the Australian regenerative medicine sector and includes an internship program that accepts undergraduate and postgraduate students from Australia’s universities. Approximately 25 per cent of late-phase clinical trials fail due to...

Continue reading


Fate and destiny: What we recently learned and still don’t know about sex determination

I was telling a friend about how sex determination could be an interesting topic for my next blog and he responded asking, “Don’t we already know everything about sex determination?” So I asked an expert: Dr. Robin Lovell-Badge, the Principal Investigator of a stem cell biology and developmental genetics laboratory at the Francis Crick Institute...

Continue reading


Just a “nibble”: New research on the cancer and natural killer cell relationship

Almost two years ago, I wrote a post about how scientists were looking for new immunotherapies to improve immunologically “cold” tumours’ responses to existing therapies. And while the findings of that article were very promising, tumour evasion of the immune system continues to vex cancer researchers. A recent study, led by Dr. Michele Ardolino from...

Continue reading